The commercialization of human organs for transplantation: The current status of the ethical debate

Current Opinion in Organ Transplantation

Volumn 11, Issue 2, 2006, Pages 130-135

  Simmerling, Mary ^a,c   Angelos, Peter ^b   Franklin, John ^b   Abecassis, Michael ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Coercion; Commercialization; Ethics; Exploitation; Justice; Sales

Indexed keywords

COMMERCIAL PHENOMENA; COMPENSATION; LIVING DONOR; MEDICAL ETHICS; ORGAN DONOR; ORGAN TRANSPLANTATION; PUBLIC OPINION; REVIEW; REWARD;

EID: 33645824755     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/01.mot.0000218924.04526.a4     Document Type: Review

References (46)

1. National Conference of Commissioners on Uniform State Laws: Uniform Anatomical Gift Act (1987). NCCUSL Meeting in Newport Beach, CA. 31 July to 7 August, 1987.
2. National Organ Transplant Act (NOTA). Pub L. No. 98-507, 3 USC g 301, 1984.
3. Delmonico FL, Arnold R, Scheper-Hughes N, Siminoff LA, Kahn J, Youngner SJ. Ethical incentives - not payment - for organ donation. N Engl J Med 2002; 346:2002-2005.
4. Punch, J. Saving lives: Making a case to test financial incentives to increase the cadaveric donor supply. Presented at the Organ Transplantation: Economic, Ethical and Policy Issues Conference at the University of Chicago, 16 May, 2003.
5. Becker G, Elias J. Introducing incentives in the market for live and cadaveric organ donations. Presented at the Organ Transplantation: Economic, Ethical and Policy Issues Conference at the University of Chicago, 16 May, 2003.
6. Abecassis M, Adams M, Adams P, et al. Live Organ Donor Consensus Group: Consensus statement on the live organ donor. JAMA 2000; 284:2919-2926.
7. Delmonico FL, Surman OS. Is this live-organ donor your patient? Transplantation 2003; 76:1257-1260.
8. Gill MB, Sade RM. Paying for kidneys: the case against prohibition. Kennedy Inst Ethics J 2002; 12:17-45.
9. Goyal M, Mehta R, Schneiderman L, Sehgal A. Economic and health consequences of selling a kidney in India. JAMA 2002; 288:1589-1593.
10. Gridelli B, Remuzzi G. Current concepts: Strategies for making more organs available for transplantation. N Engl J Med 2000; 343:404-410.
11. Radcliffe-Richards J, Daar AS, Guttmann RD, et al. The case for allowing kidney sales. International Forum for Transplant Ethics. Lancet 1998; 351:1950-1952.
12. Rothman DJ. Ethical and social consequences of selling a kidney. JAMA 2002; 288:1640-1641.
13. Veatch RM. Why liberals should accept financial incentives for organ procurement. Kennedy Inst Ethics J 2003; 13:19-36.
14. Zargooshi J. Iranian kidney donors: motivations and relations with recipients. J Urol 2001; 155:386-392.
15. Zargooshi J. Quality of life of Iranian kidney 'donors'. J Urol 2001; 166:1790-1799.
16. Byrne MM, Thompson P. A positive analysis of financial incentives for cadaveric organ donation. J Health Econ 2001; 20:69-83.
17. Daar AS. Rewarded gifting. Transplantation Proc 1992; 24:2007-2012.
18. Cohen LR. A futures market in cadaveric organs: would it work? Transplant Proc 1993; 25:60-61.
19. Eisendraft CR. Used body parts: Buy, sell or swap? Transplant Proc 1992; 24:2212-2214.
20. Childress JF. The body as property: some philosophical reflections. Transplant Proc 1990; 22:918-921.
21. Guttmann RD. Regulated commercialism in transplantation: The factitious focus. Transplant Proc 1993; 25:58-59.
22. Sells RA. Organ commerce: Ethics and expediency. Transplant Proc 1990; 22:931-932.
23. Sells RA. The case again: Buying organs and a futures market in transplants. Transplant Proc 1992; 24:2198-2202.
24. Blumstein JF. The case for comments in organ transplantation. Transplant Proc 1992; 24:2190-2197.
25. Kass LR. The wisdom of repugnance: why we should ban the cloning of humans. New Repub 1997; 216 (22):17-26.
26. Radcliffe-Richards J. Nephrarious goings on: kidney sales and moral arguments. J Med Philos 1996; 21:375-416.
27. Jasper JD, Nickerson CAE, Hershey JD, et al. The public's attitudes toward incentives for organ donation. Transplant Proc 1999; 31:2181-2184.
28. Evans JH. Commodifying life? A pilot study of opinions regarding financial incentives for organ donation. J Health Polit Policy Law 2003; 28:1003-1032.
29. Jasper JD, Nickerson CA, Ubel PA. Altruism, incentives, and organ donation: Attitudes of the transplant community. Med Care 2004; 42:378-386. This is a survey of attitudes of clinical transplant personal towards incentives for donation. The majority is not against small financial compensations.
30. Arnold R, Bartlett S, Bernat J, et al. Financial incentives for cadaver organ donation: an ethical reappraisal. Transplantation 2002; 73:1361-1367.
31. Taub S, Maixner AH, Morin K, et al. Cadeveric organ donation: encouraging the study of motivation. Transplantation 2003; 76:748-751.
32. Kishore RR. Human organs, scarcities, and sale: Morality revisited. J Med Ethics 2005; 31:362-365. This paper argues that arguments against sale of organs are forms of moral paternalism that ignore pragmatism.
33. de Castro LD. Commodification and exploitation: Arguments in favor of compensated organ donation. J Med Ethics 2003; 29:142-146.
34. Israni AK, Halpern SD, Zink S, et al. Incentive models to increase living kidney donation: encouraging without coercion. Am J Transplant 2005; 5:15-20. This article discusses the pro and cons of four models of incentives for donations: market compensation, fixed compensation, noncompensation, and the expense reimbursement.
35. Matas AJ. The case for living kidney sales: rationale objections and concerns. Am J Transplant 2004; 4:2007-2017. This article argues for the need for a regulated system of kidney sales that includes provisions for protecting donors.
36. Garcia VD, Garcia KE, Santos P. Expanding criteria for the use of living donors: What are the limits? Transplant Proc 2004; 36:808-810. This article argues for better health care and insurance benefits for organ donors.
37. Sackner-Bernstein J, Godin S. Increasing organ transplantation - fairly. Transplantation 2004; 77:157-159. The authors propose a system in which persons who prospectively agree to donate an organ at death will receive top priority should they need an organ in the future.
38. Steinberg D. An 'opting in' paradigm for kidney transplantation. Am J Bioethics 2004; 4:4-14.
39. Wigmore SJ, Forsythe JLR. Incentives to promote donation. Transplantation 2004; 77:159-161. This article discusses some of the legal and logistic challenges of incentives to increase organ donation.
40. Simmerling M, Angelos P, Frader J, Goldberg A. Do gifts create moral obligations for recipients? Am J Bioethics 2004; 4 (4):20-22.
41. Zink S, Wertlieb. Catalano J, Marwin V. Examining the potential exploitation of UNOS policies. Am J Bioeth 2005; 5 (4):6-10. Cogent argument against allowing individuals to jump the UNOS allocation system.
42. Steinbrook R. Public solicitation of organ donors. New Eng J Med 2005; 353 (5):441-443. Well-balanced presentation of the ethical issues associated with the practice of public solicitation of organ donors through various means.
43. United Network for Organ Sharing (UNOS): Memorandum Addresses Living Donor Solicitation, 12 January, 2005. Important statement of UNOS position on living donor solicitation.
44. American Society of Transplantation (AST). Statement on Solicitation of Donor Organs, 20 January, 2005. Website http://www.a-s-t.org. [Last accessed 9 August, 2005] This important position paper by the American Society of Transplant Surgeons attempts to distinguish internet relationships from other types of relationships such as those made through clubs or churches.
45. Caplan A, Zink S, Wertlieb S. Jumping to the front of the line for an organ transplant is unfair. Chicago Tribune. 1 September, 2004; 27.
46. Caplan A. Organs.com: new commercially brokered organ transfers raise questions. Hastings CentRep 2004; 34 (6):8. Concise argument against internet-brokered organ transplantation.